110710 ⎘
ssRNA viruses negative-sense; Details; Bunyaviridae; Phlebovirus, e.g. Rift Valley fever virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
BUNYAVIRALES VACCINE
#2MULTIVALENT VIRAL PARTICLES
#3BUNYAVIRALES VACCINE
#4ATTENUATED VARIANT OF THE RIFT VALLEY FEVER VIRUS, COMPOSITION COMPRISING SAME, AND USES THEREOF
#5DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)
#6Bunyavirales vaccine
#7Attenuated virus having multiple hosts
#8Recombinant rift valley fever (RVF) viruses and methods of use
#9Bunyaviruses with segmented glycoprotein precursor genes and methods for generating these viruses
#10LONE STAR VIRUS
#11Bovine virus vaccines that are liquid stable
#12Methods to produce bunyavirus replicon particles
#13Virus-like particles, methods of preparation, and immunogenic compositions
#14Rift valley fever virus replicon particles and use thereof
#15Pathogenic phlebovirus isolates and compositions and methods of use
#16Bovine virus vaccines that are liquid stable
#17Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use
#18Recombinant rift valley fever (RVF) viruses and methods
#19Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region
#20Methods to produce bunyavirus replicon particles
#21BUNYAVIRUS VACCINE
#22USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#23Recombinant Rift Valley fever (RVF) viruses and methods of use
#24RIFT VALLEY FEVER VIRUS-LIKE PARTICLES AND THEIR USE FOR IMMUNIZATION AND AS TEST SYSTEM
#25VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS
#26MOMLV-BASED PSEUDOVIRION PACKAGING CELL LINE
#27Reverse genetic system for rift valley fever virus and uses thereof
#28Virus-like particles, methods of preparation, and immunogenic compositions